SCHEMBL7474934

SCHEMBL7474934

CCCCCNc1nc(CC)c(-c2ccc(Cl)cc2C)nc1CC

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 19/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7482439 0.89 CRHR1 (0.53) CRHR1
SCHEMBL7469231 0.86 TLR8 (0.41) CRHR1
SCHEMBL5427390 0.83 CRHR1 (0.47) CRHR1
SCHEMBL6074443 0.82 CRHR1 (0.65) CRHR1
SCHEMBL6080630 0.78 CRHR1 (0.80) CRHR1
SCHEMBL6075781 0.77 CRHR1 (0.67) CRHR1
SCHEMBL27501034 0.77 CRHR1 (0.65) CRHR1
SCHEMBL7474850 0.77 CRHR1 (0.46) CRHR1
SCHEMBL7481401 0.77 CRHR1 (0.65) CRHR1
SCHEMBL6166393 0.75 CRHR1 (0.42) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed